ARIAKE JAPAN (2815) FY2026 Q3 Earnings Report

Quick View

Executive Summary

For the cumulative Q3 period of the fiscal year ending March 2026, Ariake Japan posted higher revenue and earnings, delivering a high-quality set of results in which profit growth exceeded revenue growth. Against revenue of ¥49.93B (+2.2% YoY), Operating Income was ¥8.77B (+7.2%), Ordinary Income was ¥10.17B (+14.3%), and Net Income was ¥6.97B (+14.3%), securing earnings growth rates significantly above the revenue growth rate. The Operating Income margin improved to 17.6% from 16.7% in the same period of the previous year, supported by cost reductions at the Company’s standalone factories and higher earnings at European subsidiaries. The fact that Ordinary Income growth exceeded Operating Income growth was attributable to an increase in non-operating income, including dividend income and foreign exchange gains.

Factors Affecting Results

【Revenue】Consolidated revenue was ¥49.93B, representing moderate growth of +2.2% YoY. Standalone revenue was ¥36.81B (+1.3%), driven by B2B2C products, while revenue from CVS customers declined by -5.5%. Aggregate subsidiary revenue was ¥13.12B (+4.7%; -1.3% on a foreign-exchange-neutral basis). Europe, centered on France and Belgium, grew by +14.3% and offset Asia (-1.9%), where economic weakness continued in China, Taiwan, and other markets.

【Profit and Loss】Operating Income was ¥8.77B (+7.2%), outpacing revenue growth. The primary factors were standalone factory cost reductions, which progressed to approximately ¥2.3B against the annual plan of approximately ¥2.0B (114% achievement rate), and fixed-cost absorption at European subsidiaries. Ordinary Income was ¥10.17B (+14.3%), boosted by non-operating income of ¥1.49B, including dividend income of ¥0.23B and foreign exchange gains of ¥0.53B. Extraordinary losses were limited to ¥0.09B in losses on disposal of fixed assets, so the impact of temporary factors was limited. Net Income of ¥6.97B (+14.3%) grew at nearly the same rate as Ordinary Income, supporting the conclusion that the Company achieved both revenue and earnings growth.

Segment Analysis

As the Company operates in a single segment, natural seasonings, its disclosures are based on the standalone Company and subsidiaries by region. In terms of revenue composition, the standalone Company accounts for approximately 73.7% of total revenue and represents the core business. Operating Income was ¥6.17B (+5.7%; margin of 16.8%) for the standalone Company and ¥2.59B (+11.2%; margin of 19.8%) for subsidiaries in aggregate, with subsidiaries achieving a higher profit margin than the standalone Company. By region, Europe posted a significant increase in Operating Income to ¥0.89B (+59.6%), offsetting the decline in Asia, where Operating Income decreased to ¥1.71B (-2.6%). The primary drivers of earnings growth were standalone factory cost reductions and fixed-cost absorption at European subsidiaries, while the economic downturn in Asia was the sole factor contributing to earnings decline.

Key Financial Metrics

Profitability: ROE of 5.3% and Operating Income margin of 17.6% (16.7% in the previous year) Cash flow quality: As Operating Cash Flow data has not been disclosed, the multiple relative to Net Income cannot be calculated; however, the Company maintains ample on-hand liquidity, with cash and deposits of ¥48.79B Investment efficiency: Capital expenditures for the cumulative three-quarter period were ¥1.68B on a consolidated basis and ¥1.26B on a standalone basis, progressing as planned Financial soundness: Equity Ratio of 87.9% and current ratio of 688.5% (current assets of ¥78.75B / current liabilities of ¥11.44B)

Cash Flow Analysis

As separate disclosures for Operating Cash Flow, investing cash flow, and financing cash flow are not available, funding trends are assessed based on changes in the balance sheet. Cash and deposits remained high at ¥48.79B, while investment securities increased by ¥8.05B YoY to ¥41.04B, indicating strengthened fund management. Consolidated capital expenditures were ¥1.68B, reflecting an emphasis on securing funding for future investments, including the planned new U.S. factory of Ariake U.S.A. Inc. Accounts receivable increased significantly to ¥16.41B (+28.2% from ¥12.80B in the previous year), indicating increased funds tied up in working capital, which warrants attention from a cash generation perspective. Cash generation is assessed as standard given the substantial on-hand liquidity, although monitoring of deterioration in working capital due to increases in accounts receivable and inventory is necessary.

Quality of Earnings

Ordinary Income of ¥10.17B differs from Net Income of ¥6.97B only by income taxes and other taxes of ¥3.13B (effective tax rate of 31.0%), representing a divergence attributable to the ordinary tax burden with no particular qualitative concern. Non-operating income of ¥1.49B is equivalent to 3.0% of revenue and below the 5% benchmark, but attention is warranted because it consists of items affected by market conditions, including foreign exchange gains of ¥0.53B, interest income of ¥0.52B, and dividend income of ¥0.23B. Extraordinary gains and losses consisted solely of ¥0.09B in losses on disposal of fixed assets and were immaterial. Comprehensive Income of ¥7.84B exceeded Net Income by ¥0.96B, owing to positive contributions from valuation differences on securities and foreign currency translation adjustments; this does not impair the quality of earnings from the core business.

Earnings Forecast and Guidance

There has been no change to the full-year plan (Revenue of ¥67.11B and Operating Income of ¥12.22B). Progress rates were 74.4% for Revenue, 71.7% for Operating Income, 78.8% for Ordinary Income, and 79.1% for Net Income. Revenue was close to the standard progress level of 75%, while Operating Income was slightly below that level. The fact that progress in Ordinary Income and Net Income exceeded progress in Operating Income was attributable to the contribution from non-operating income. Achieving the full-year Operating Income margin target of 18.2% will require an improvement in the Q4 profit margin. Management aims to achieve the plan by increasing standalone sales in the second half and offsetting weakness in Asia through higher earnings in Europe.

Shareholder Returns

The Q2 dividend was ¥60.00 per share, while the full-year dividend forecast is ¥180.00 annually. Based on forecast EPS of ¥273.17, the Payout Ratio is approximately 65.9%, representing a dividend-only metric. No share repurchases have been confirmed, so dividends are the only component subject to calculation of the Total Return Ratio. The Company’s financial foundation, including an Equity Ratio of 87.9% and cash and deposits of ¥48.79B, supports the sustainability of shareholder returns even with the Payout Ratio at a somewhat high level.

Catalysts

【Short Term】Recovery in standalone sales in Q4 (expected at +2.5~3.5% YoY), demand trends among CVS customers, and whether the impact on costs from a stronger-than-expected euro becomes apparent.

【Long Term】Commencement of exports to Japan of halal-certified ramen soup from the Indonesian factory (January 2026), the outlook for European subsidiaries—particularly Belgium—to achieve full-year profitability, and progress on the planned new U.S. factory of Ariake U.S.A. Inc., including the status of any revisions to the scale of investment.

Industry Benchmark (Reference; Compiled by the Company)

Profitability and Returns

Both the Company’s Operating Income margin and Net Income margin significantly exceed the industry median, indicating a high level of profitability within the food and beverage industry.

Growth and Capital Efficiency

The Company’s revenue growth rate is slightly below the industry median. In exchange for high profitability, its growth pace is in line with or somewhat slower than the industry average.

※Source: Compiled by the Company

Risk Factors

1. Working capital tied up: Accounts receivable increased by +28.2% YoY to ¥16.41B, substantially exceeding the standalone Company’s revenue growth rate (+1.3%). Inventory also remains at a high level, including raw materials of ¥6.03B, requiring monitoring from a capital efficiency perspective.

2. Raw material and foreign exchange costs: Raw materials for natural seasonings depend on livestock, agricultural and marine products, and imported materials. A stronger-than-expected euro would increase costs at European locations. The ability to pass through costs remains important to maintaining the gross profit margin of 30.9%.

3. Weak demand in Asia: Due to weak consumption in China and Taiwan, revenue at Asian subsidiaries declined by -1.9% YoY (-5.4% on a foreign-exchange-neutral basis), while Operating Income also declined by -2.6%. The key focus is whether the offsetting structure created by earnings growth in Europe will continue.

Key Takeaways from the Earnings Results

1. The Operating Income margin of 17.6% improved by +0.9pt YoY and is substantially above the industry median. Standalone factory cost reductions (114% achievement rate versus the annual plan) and fixed-cost absorption at European subsidiaries contributed to a structural improvement in profitability.

2. Progress rates for Ordinary Income and Net Income (78.8% and 79.1%) exceeded the Operating Income progress rate (71.7%), indicating a profit structure with relatively high dependence on non-operating income, such as foreign exchange gains and interest income. This point warrants confirmation when assessing the quality of earnings at the Ordinary Income level.

3. The sharp increase in accounts receivable (+28.2%) substantially exceeded the revenue growth rate (+2.2%). Although it remains within an absorbable range given the strength of the financial base (Equity Ratio of 87.9% and cash and deposits of ¥48.79B), it warrants close monitoring as a structural change in working capital efficiency.

Theoretical Share Price (Reference Value)

Sensitivity: ¥3,671–¥3,876 at ±1% for the Cost of Equity, and ¥3,762–¥3,777 at ±0.1 for ω.

Notes:

• Because forecast ROE is below the Cost of Equity, the theoretical value is below Book Value per Share.
• Net assets as of the quarter-end are used (there is a time lag relative to the full-year forecast).

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest-rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee the future share price.)

---

This report is an earnings analysis document automatically generated through an AI-integrated analysis of XBRL earnings summary data and PDF earnings presentation materials. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Ariake Japan delivered a solid FY2026 Q3 result, with modest sales growth translating into faster operating and net-profit growth. Cumulative revenue for the nine months rose 2.2% YoY to ¥49.93bn. Operating income increased 7.2% to ¥8.77bn. Ordinary income rose 14.3% to ¥10.17bn. Profit attributable to owners increased 14.6% to ¥6.89bn. The gross margin improved by 83bp YoY to 30.9%, from approximately 30.0% in the prior-year period. The operating margin also expanded by 83bp to 17.6%, reflecting operating-profit growth materially ahead of revenue growth. The net margin improved by approximately 149bp to 13.8%, supported by stronger non-operating income. Interest income of ¥0.52bn, dividend income of ¥0.23bn and FX gains of ¥0.53bn contributed to non-operating income of ¥1.49bn. Consequently, ordinary-income growth outpaced operating-income growth, indicating that part of the bottom-line upside was generated outside the core natural-seasoning business. The effective tax rate was 31.0%, with a tax burden of 0.681. The balance sheet remains exceptionally conservative, with a 688.5% current ratio, 641.4% quick ratio and 0.14x debt-to-equity ratio. Cash and deposits of ¥48.79bn and investment securities of ¥41.04bn provide substantial financial flexibility. However, receivables increased 28.2% YoY to ¥16.41bn, while the reported DSO of 90 days, DIO of 102 days and cash conversion cycle of 148 days point to an extended cash cycle. R&D expenditure was ¥0.39bn, or 0.8% of sales, which is low for a company whose differentiation depends on product formulation and natural-seasoning technology. Against full-year guidance, Q3 progress is 74.4% for sales, 71.7% for operating income, 78.8% for ordinary income and 79.1% for profit attributable to owners. The sales trajectory is broadly in line with the standard 75% Q3 run rate, while operating-income progress is 3.3 percentage points below it and ordinary-income and net-income progress are ahead of it. The full-year earnings target appears supported by the nine-month result, although the composition of non-operating income and working-capital normalization will remain important for assessing earnings quality.

Profitability Analysis

The reported annualized DuPont ROE is 7.0%, decomposed into a 13.8% net profit margin, 0.447x annualized asset turnover and 1.14x financial leverage. The company generates strong profitability per unit of sales, but its large cash and investment-security base depresses asset turnover and limits ROE despite very low financial risk. Financial leverage is conservative and is not a material contributor to returns. The principal operational improvement was margin expansion: gross margin increased 83bp to 30.9% and operating margin increased 83bp to 17.6%. Cost of sales grew only 1.0% YoY, versus 2.2% revenue growth, evidencing favorable gross-profit conversion. SG&A increased 2.2% YoY to ¥6.64bn, broadly matching revenue growth and therefore did not dilute the gross-margin improvement. R&D expense was broadly flat at ¥0.39bn and represented only 0.8% of revenue. EBIT margin was 17.6%, well above the 15% threshold generally associated with excellent profitability. Net-margin expansion exceeded operating-margin expansion because non-operating income increased to ¥1.49bn from ¥1.01bn, notably FX gains of ¥0.53bn and interest income of ¥0.52bn. Interest burden of 1.153 reflects net non-operating financial income rather than debt-funded operations, while interest coverage of 12,503.6x confirms negligible financing-cost pressure. The sustainable component of the earnings improvement is the gross-margin and operating-margin expansion; the incremental benefit from FX gains is more variable. With annualized asset turnover at 0.447x and annualized ROE at 7.0%, future return enhancement would depend more on productive deployment of surplus financial assets and operating growth than on additional leverage.

Growth Assessment

Revenue growth of 2.2% YoY was moderate, but operating income growth of 7.2% demonstrates positive operating leverage through gross-margin expansion and controlled SG&A. As a single-segment natural-seasoning business, the group’s performance is concentrated in its core business rather than diversified across separately disclosed operating segments. The 30.9% gross margin is within the healthy 25-40% food-industry range and suggests meaningful value addition and formulation capability. FY2026 full-year guidance calls for revenue of ¥67.11bn, up 2.6% YoY, and operating income of ¥12.22bn, up 9.9% YoY. Q3 sales progress of 74.4% is essentially aligned with the standard 75% run rate, indicating that the top-line target requires no material acceleration in Q4. Operating-income progress of 71.7% is below the standard 75% run rate, so Q4 requires a stronger operating margin than the nine-month average to meet the full-year target. Ordinary-income progress of 78.8% and net-income progress of 79.1% are ahead of the standard run rate, but these outcomes have been assisted by non-operating income. The ¥0.53bn FX gain is not necessarily repeatable and makes ordinary-income outperformance less indicative of core operational momentum. Raw-material inventory rose 31.4% YoY to ¥6.03bn, which increases exposure to commodity-price movements and inventory management execution. Low R&D intensity of 0.8% is a strategic concern because insufficient innovation investment could constrain differentiated product launches, customer solutions and long-term pricing power in natural seasonings. Growth quality would improve if future sales expansion is accompanied by stable working-capital efficiency and recurring operating-profit growth rather than financial and currency gains.

Financial Health

Financial health is very strong. Current assets of ¥78.75bn exceed current liabilities of ¥11.44bn by ¥67.31bn, producing a 688.5% current ratio and ¥67.31bn of working capital. The 641.4% quick ratio shows that liquidity is not dependent on inventory liquidation. Cash and deposits of ¥48.79bn alone are more than four times current liabilities. Total liabilities were only ¥18.02bn, equivalent to 12.1% of total assets, while total equity was ¥130.79bn. Debt-to-equity of 0.14x is conservative and materially below the 2.0x high-leverage warning threshold. There is no maturity-mismatch concern: current assets substantially cover short-term liabilities, and lease obligations are immaterial relative to liquidity. The principal balance-sheet monitoring point is receivables, which rose ¥3.61bn, or 28.2% YoY, to ¥16.41bn and account for 11.0% of total assets. The reported DSO of 90 days is above the 60-day quality-alert threshold, indicating slower cash collection or a sales mix with longer customer payment terms. Investment securities increased ¥7.74bn YoY to ¥41.04bn and represent 27.6% of total assets; together with cash, this underscores substantial financial-asset exposure. Deferred tax liabilities of ¥5.34bn are significant relative to non-current liabilities and are consistent with the importance of unrealized valuation gains in the investment portfolio. Net defined-benefit liability declined to ¥0.98bn from ¥1.24bn, modestly reducing long-term obligation risk. Intangible assets are only 0.1% of total assets, so the balance sheet has no material goodwill or acquired-intangible concentration. One subsidiary was newly consolidated and one was excluded during the period, requiring monitoring of comparability and execution, although the group remains financially well capitalized.

Notable B/S Changes

Accounts receivable: +¥3.61bn (+28.2%) to ¥16.41bn — growth materially exceeded revenue growth, consistent with the elevated 90-day DSO and requiring collection monitoring. Cash and deposits: -¥10.17bn (-17.3%) to ¥48.79bn — liquidity remains exceptionally strong, but the movement should be assessed alongside increased investment securities and working-capital needs. Investment securities: +¥7.74bn (+24.1%) to ¥41.04bn — a large financial-asset allocation representing 27.6% of assets; valuation changes can affect OCI, equity and deferred tax liabilities. Investments and other assets: +¥8.00bn (+21.8%) to ¥44.70bn — the absolute increase exceeds ¥5bn and reflects further expansion of non-operating financial assets. Raw materials: +¥1.44bn (+31.4%) to ¥6.03bn — higher procurement inventory increases commodity-price, supply-chain and working-capital exposure. Total equity: +¥2.40bn (+1.9%) to ¥130.79bn — equity remains the dominant funding source and supports the company’s low-leverage profile.

Cash Flow Quality

The working-capital profile warrants careful attention in assessing cash-flow conversion. Accounts receivable increased ¥3.61bn YoY to ¥16.41bn and the reported DSO of 90 days exceeds the 60-day alert threshold; this can delay conversion of reported sales and profit into operating cash. The reported DIO of 102 days exceeds both the 90-day quality-alert threshold and the processed-food benchmark of below 60 days, increasing the risk of cash being tied up in stock and of inventory valuation pressure if demand or input costs change. The reported cash conversion cycle of 148 days is above the 120-day quality-alert threshold and materially above the food-industry benchmark of below 60 days. This long cycle is the combined result of elevated receivable and inventory days and should be monitored for potential working-capital drag. Finished goods were ¥5.39bn, while raw materials rose 31.4% YoY to ¥6.03bn; the increase in raw-material holdings suggests higher commodity and supply-chain exposure. Accounts payable increased to ¥5.56bn and electronically recorded obligations rose to ¥1.37bn, providing some supplier-financing offset, but these increases do not remove the need to improve collections and inventory turnover. The cash and investment-security base gives the group capacity to absorb temporary working-capital needs without liquidity stress. However, the quality of future earnings will be stronger if receivables and inventory grow more slowly than revenue and the cash conversion cycle contracts. Low R&D intensity of 0.8% is also relevant to long-term cash-flow quality: maintaining product differentiation may require a higher reinvestment rate over time.

Dividend Sustainability

The full-year forecast DPS is ¥180, compared with ¥60 paid at Q2. Based on forecast EPS of ¥273.17, the implied full-year dividend payout ratio is approximately 65.9%. This is above the 60% sustainability benchmark but remains below 100%, indicating that the planned dividend is covered by forecast earnings. The company’s very strong liquidity, low debt-to-equity ratio of 0.14x and substantial cash and investment securities provide a substantial buffer for dividend continuity. Retained earnings were ¥99.21bn, reinforcing balance-sheet capacity for shareholder distributions. The Q2 dividend of ¥60 represented an interim distribution consistent with the ¥180 full-year plan. Dividend sustainability is therefore primarily dependent on preserving ordinary operating profitability rather than access to financing. The key qualification is that nine-month net-income growth has benefited from interest income, dividends and FX gains; a dividend policy calibrated to recurring operating cash generation would be more resilient through periods of lower financial income or adverse currency movements. Extended receivable and inventory days should also be monitored because persistent working-capital absorption can reduce distributable cash conversion even when accounting earnings remain strong.

Risk Assessment

Business risks include Working-capital efficiency risk: DSO of 90 days, DIO of 102 days and a 148-day cash conversion cycle are elevated for a food manufacturer and can delay cash realization., Commodity and supply-chain risk: raw-material inventory rose 31.4% YoY to ¥6.03bn, increasing exposure to agricultural-input price volatility, procurement disruption and inventory valuation pressure., Food-industry execution risk: natural-seasoning products face food-safety, quality-control, customer concentration, private-brand competition and changing consumer or food-service demand risks., Innovation risk: R&D intensity of 0.8% is below the 3% quality-alert threshold and may limit new-product development and long-term differentiation if maintained., Foreign-exchange risk: FX gains of ¥0.53bn contributed to FY2026 Q3 ordinary income, so currency movements can create volatility in earnings outside the core operating result..

Financial risks include Receivables rose 28.2% YoY, materially faster than 2.2% sales growth; this may signal slower collection, customer mix changes or temporarily elevated period-end billing., Investment securities of ¥41.04bn, or 27.6% of total assets, expose comprehensive income and equity to market-value fluctuations; deferred tax liabilities of ¥5.34bn also reflect unrealized-gain exposure., The forecast dividend payout ratio of approximately 65.9% exceeds the stated 60% sustainability benchmark, reducing flexibility relative to a lower-payout policy., Financial risk from debt is low: debt-to-equity is 0.14x, liquidity is ample and interest coverage is exceptionally high..

Key concerns include Highest priority: normalization of the 148-day cash conversion cycle, particularly whether receivables collection and inventory turnover improve in Q4., High priority: whether the company achieves full-year operating-income guidance despite Q3 operating-income progress of 71.7%, below the 75% seasonal reference point., Medium priority: durability of margin expansion amid raw-material, energy, packaging and logistics cost volatility., Medium priority: the extent to which ordinary-income growth remains dependent on non-operating financial income and FX gains., Medium priority: whether low R&D spending is sufficient to sustain product differentiation and pricing power..

Investment Implications

Key takeaways include Nine-month operating performance was positive: revenue grew 2.2%, operating income rose 7.2%, and operating margin expanded 83bp to 17.6%., Profitability is strong, with a 30.9% gross margin, 13.8% net margin and reported annualized ROE of 7.0%., The balance sheet is highly defensive, supported by ¥48.79bn of cash, ¥41.04bn of investment securities, a 688.5% current ratio and 0.14x debt-to-equity., Ordinary-income and net-income outperformance partly reflects interest income, dividends and FX gains rather than solely core operating improvement., Receivable, inventory and cash-cycle metrics are the principal operational watchpoints despite the group’s ample liquidity..

Metrics to watch include Q4 operating margin required to close the gap between 71.7% Q3 operating-income progress and the full-year ¥12.22bn target., DSO, currently 90 days, and the rate of accounts-receivable growth relative to revenue., DIO, currently 102 days, raw-material inventory levels and inventory valuation risk., Cash conversion cycle, currently 148 days, and its effect on cash realization., Recurring operating income relative to FX gains, interest income and dividend income., R&D intensity, currently 0.8% of revenue, as an indicator of long-term product-development investment., Investment-security valuation movements and their impact on other comprehensive income and equity., Achievement of the FY2026 ¥180 DPS plan and the implied approximately 65.9% payout ratio..

Regarding relative positioning, Ariake Japan is positioned as a high-margin, conservatively financed food-ingredient manufacturer with unusually substantial financial assets and limited balance-sheet leverage. Its 30.9% gross margin and 17.6% operating margin compare favorably with typical food-industry profitability benchmarks. Relative to a cash-efficient food manufacturer, however, the 90-day DSO, 102-day DIO and 148-day cash conversion cycle are weak and require operational improvement. The company’s annualized 7.0% ROE is below the 8% caution threshold despite strong margins, largely because the sizable asset base suppresses turnover and leverage is intentionally low.